The present invention describes an association between genetic polymorphismsin the BAI3 gene and a predispositionto prolongation of the QT interval, and provides related methods for theprediction of such a predisposition, the administrationof QT interval-prolonging compounds to individuals having such apredisposition, and determining whether a compound iscapable of inducing QT prolongation.